(23S,24S)-3-beta-23,24-Trihydroxyspirosta-5,25(27)-dien-1-beta-yl-O-alpha-L-rham nopyrano syl)- (1→2)-O-[beta-D-xylopyranosyl-(1→3)]-alpha-L-ara binopyranoside - Compound Card

(23S,24S)-3-beta-23,24-Trihydroxyspirosta-5,25(27)-dien-1-beta-yl-O-alpha-L-rham nopyrano syl)- (1→2)-O-[beta-D-xylopyranosyl-(1→3)]-alpha-L-ara binopyranoside

Select a section from the left sidebar

(23S,24S)-3-beta-23,24-Trihydroxyspirosta-5,25(27)-dien-1-beta-yl-O-alpha-L-rham nopyrano syl)- (1→2)-O-[beta-D-xylopyranosyl-(1→3)]-alpha-L-ara binopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Saponin
Canonical Smiles O[C@H]1C[C@@H](O[C@@H]2OC[C@@H](C([C@@H]2O[C@@H]2OC(C)[C@@H]([C@@H](C2O)O)O)O[C@@H]2OC[C@H](C([C@@H]2O)O)O)O)[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3C[C@H]3[C@@H]2[C@H](C)[C@@]2(O3)OCC(=C)C(C2O)O)C)C1)C
InChI InChI=1S/C43H66O18/c1-16-13-56-43(37(53)29(16)47)17(2)28-26(61-43)12-23-21-7-6-19-10-20(44)11-27(42(19,5)22(21)8-9-41(23,28)4)58-40-36(60-39-34(52)32(50)30(48)18(3)57-39)35(25(46)15-55-40)59-38-33(51)31(49)24(45)14-54-38/h6,17-18,20-40,44-53H,1,7-15H2,2-5H3/t17-,18?,20+,21+,22-,23-,24+,25-,26-,27+,28-,29?,30-,31?,32-,33-,34?,35?,36-,37?,38-,39-,40-,41-,42-,43-/m0/s1
InChIKey BTPXTFRSIGTXMO-YHULUEQDSA-N
Formula C43H66O18
HBA 18
HBD 10
MW 870.98
Rotatable Bonds 6
TPSA 276.14
LogP -1.68
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 61
Formal Charge 0
Fraction CSP3 0.91
Exact Mass 870.42
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria trifasciata Dracaenaceae Plantae 39534

Showing of synonyms

  • Teponno RB, Tanaka C, et al. (2016). Trifasciatosides A-J, Steroidal Saponins from Sansevieria trifasciata.. Chemical & pharmaceutical bulletin,2016, 64(9), 1347-1355. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7OCCC(OC8CCCCO8)C7OC9CCCCO9

Level: 3

Mol. Weight: 870.98 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCCC7)C7OC8CCCCO8

Level: 2

Mol. Weight: 870.98 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCC7)CC7OC8CCCCO8

Level: 2

Mol. Weight: 870.98 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 870.98 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCCCO7

Level: 1

Mol. Weight: 870.98 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 870.98 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 870.98 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6

Level: 0

Mol. Weight: 870.98 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 870.98 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.53
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
673.34
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
88783.38

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.79
Plasma Protein Binding
73.3
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.6
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Toxic
Bioconcentration Factor
-2060.07
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.26
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.51
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-161137827.16
Rat (Acute)
3.99
Rat (Chronic Oral)
4.96
Fathead Minnow
203408.49
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
18120067.99
Hydration Free Energy
-2.92
Log(D) at pH=7.4
1.19
Log(P)
0.23
Log S
-2.58
Log(Vapor Pressure)
-596518.88
Melting Point
259.23
pKa Acid
-4269.58
pKa Basic
-3.53
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.7361

Download SDF